Related Experiment Videos
Use of molecular simulation for mapping conformational CYP2E1 epitopes
Matteo Vidali1, Mats Hidestrand, Erik Eliasson
1Department of Medical Science, University Amedeo Avogadro of East Piedmont and Interdipartimental Research Center for Autoimmune Diseases (IRCAD), 28100 Novara, Italy.
The Journal of Biological Chemistry
|October 1, 2004
Summary
Identifying conformational epitopes on cytochrome P450 2E1 (CYP2E1) is challenging. This study used molecular modeling and single amino acid substitutions to pinpoint key regions on CYP2E1 recognized by autoantibodies in liver disease patients.
Area of Science:
- Biochemistry
- Immunology
- Toxicology
Background:
- Autoantibodies against cytochrome P450s (CYPs) are implicated in drug-induced hepatotoxicity.
- Identifying conformational epitopes on CYPs, like CYP2E1, is difficult due to their complex structures.
Purpose of the Study:
- To identify conformational epitopes on CYP2E1 recognized by autoantibodies.
- To investigate the role of specific amino acid residues in CYP2E1 antigenicity.
Main Methods:
- Generated a molecular model of CYP2E1 based on the CYP2C5 crystal structure.
- Performed single amino acid substitutions on CYP2E1 and produced variants.
- Evaluated autoantibody recognition using immunoprecipitation assays with patient sera.
Main Results:
- Specific amino acid substitutions (e.g., Glu-248, Lys-251, Lys-324, Lys-342, Lys-420, Phe-421) significantly reduced or abolished CYP2E1 recognition by autoantibodies.
- Identified two distinct epitopes on the CYP2E1 surface: one on the G-helix and another near the J' and K'' helices.
- Demonstrated that other substitutions had minimal impact on antibody binding.
Conclusions:
- The combined approach of molecular modeling and single amino acid mutagenesis is effective for characterizing conformational epitopes.
- Specific regions on CYP2E1 are critical for autoantibody recognition in patients with halothane hepatitis and alcoholic liver disease.